Not all sufferers with CLL require therapy. Despite all modern improvements, the iwCLL nevertheless suggests watchful observation for people with asymptomatic disease.86 This recommendation is based on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Equally trials concluded that early https://shant909qjb1.azzablog.com/profile